- Teen band 1Type releases single to raise awareness of type 1 diabetes
- Gene Weaver awarded Gates Foundation grant for programmable gene insertion platform
- Ochre Bio appoints Elaine Sullivan as senior independent non-executive director
- NICE recommends mirikizumab (Omvoh ▼) for previously treated moderately to severely active Crohn’s disease 1
- DEBRA Research and Dermaliq Therapeutics collaborate to advance treatment for rare skin disorder
- Ryvu Therapeutics appoints Justyna Żółtek to management board
- Neogap receives approval to administer full dose in cell therapy trial for colorectal cancer
- TQ Therapeutics acquires Juno GmbH to support decentralised cell therapy platform
- UK Researcher Wins Prestigious IBSA Foundation Fellowship for Pioneering Dermatology Study
- Orientation Marketing appoints Sarah Darcy as sales operations executive
- The Royal Marsden launches AI radiology platform to revolutionise cancer care
- MC2 Therapeutics appoints Trine Ahlgreen as new CEO
- Moderna doses first US patient in phase 1 trial of mRNA-4106 for solid tumours
- NICE recommends treatment for chronic kidney disease, IgA nephropathy
- CHMP issues positive opinion for Blenrep combinations in relapsed/refractory multiple myeloma